logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2008 or most recent year available [see all tables in this series...]

Part (ii) Outpatient clients by primary drug and mean age, gender ratio

Primary drugMean ageGender ratio
Amphetamines302
Ecstasy242

Notes:

 Countries providing data: BE, BG, CZ, DK, EE, IE, EL, ES, FR, IT, CY , LU, HU, MT, NL, AT, RO, SI, SK, FI, SE, UK, HR 

 Data for Spain refer to 2007. Data for Malta refer to 2006. Data for Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Standard table 3. See Table TDI-0 for details on sources. See also TDI-5. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010